Workflow
特一药业(002728)8月1日主力资金净流入1427.64万元

Group 1 - The core viewpoint of the news is that Te Yi Pharmaceutical (002728) has shown significant financial growth in its latest quarterly report, with a notable increase in revenue and net profit [1] - As of August 1, 2025, Te Yi Pharmaceutical's stock price closed at 9.48 yuan, reflecting a 2.38% increase, with a trading volume of 545,600 hands and a transaction amount of 520 million yuan [1] - The company reported total revenue of 295 million yuan for Q1 2025, representing a year-on-year growth of 79.29%, and a net profit attributable to shareholders of 31.57 million yuan, up 244.82% year-on-year [1] Group 2 - Te Yi Pharmaceutical has made investments in 8 companies and participated in 459 bidding projects, indicating active engagement in business expansion [2] - The company holds 59 trademark registrations and 76 patents, showcasing its commitment to intellectual property development [2] - Te Yi Pharmaceutical has obtained 618 administrative licenses, reflecting its compliance and operational capabilities in the pharmaceutical industry [2]